Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study.
Vera E, Christ A, Grajkowska E, Briceno N, Choi A, Crandon SK, Wall K, Lindsley M, Leeper HE, Levine J, Reyes J, Acquaye AA, King AL, Jammula V, Roche K, Rogers JL, Timmer M, Boris L, Lollo N, Panzer M, Polskin L, Pillai T, Burton E, Penas-Prado M, Theeler B, Gilbert MR, Armstrong TS, Mendoza TR. Vera E, et al. EClinicalMedicine. 2022 Nov 12;55:101718. doi: 10.1016/j.eclinm.2022.101718. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36386035 Free PMC article.
Clinical impact of molecular profiling in rare brain tumors.
Pratt D, Penas-Prado M, Gilbert MR. Pratt D, et al. Among authors: penas prado m. Curr Opin Neurol. 2023 Dec 1;36(6):579-586. doi: 10.1097/WCO.0000000000001211. Epub 2023 Oct 4. Curr Opin Neurol. 2023. PMID: 37973025 Review.
Bevacizumab use in disseminated choroid plexus papilloma.
Anderson MD, Theeler BJ, Penas-Prado M, Groves MD, Yung WK. Anderson MD, et al. J Neurooncol. 2013 Sep;114(2):251-3. doi: 10.1007/s11060-013-1180-9. Epub 2013 Jun 13. J Neurooncol. 2013. PMID: 23761024 No abstract available.
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WK, Gilbert MR; MD Anderson Community Clinical Oncology Program; Brain Tumor Trials Collaborative. Penas-Prado M, et al. Neuro Oncol. 2015 Feb;17(2):266-73. doi: 10.1093/neuonc/nou155. Epub 2014 Sep 19. Neuro Oncol. 2015. PMID: 25239666 Free PMC article. Clinical Trial.
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WKA, de Groot JF. Weathers SP, et al. J Neurooncol. 2016 Sep;129(3):487-494. doi: 10.1007/s11060-016-2195-9. Epub 2016 Jul 12. J Neurooncol. 2016. PMID: 27406589 Free PMC article. Clinical Trial.
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M. Chang S, et al. Neuro Oncol. 2017 Feb 1;19(2):252-258. doi: 10.1093/neuonc/now236. Neuro Oncol. 2017. PMID: 27994066 Free PMC article. Clinical Trial.
100 results